Symptoms and frequency of relapses vary widely from person to person with the most common form of multiple sclerosis — and doctors aren’t entirely sure why. But, what exactly does a relapse look like?

The goal of this double-blind, adaptive, dose-ranging, phase 2 study was to assess safety, tolerability and dose-response characteristics of siponimod and its effects on brain MRI lesion activity in ...

Disability accumulation may occur independently of relapses for some patients in the early phase of relapsing-remitting multiple sclerosis (MS), according to new research. Approximately 61% of ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Patients with relapsing remitting multiple sclerosis (RRMS) who received Sanofi Genzyme’s Lemtrada ® (alemtuzumab) experienced effects of treatment on disease ...

DelveInsight’s, “Relapsing-Remitting Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Relapsing-Remitting Multiple ...

Please provide your email address to receive an email when new articles are posted on . Individuals enrolled in the open-label extension experienced low discontinuation rates. Those who remained in ...

Multiple sclerosis is a disorder of the immune system, where the myelin coating the nerve cells is damaged by antibodies formed by the defence system of the body. This affects the functioning of the ...

If your doctor says you have secondary progressive multiple sclerosis (SPMS), it means you're in a different stage of your disease. Most folks get it after living for a while with relapsing-remitting ...

The best way to manage relapsing-remitting multiple sclerosis (RRMS) is with a disease-modifying agent. Newer medications are effective at decreasing rates of new lesions, reducing relapses, and ...

—To some extent, yes, say the results of a recent systematic review and meta-analysis. But were escalation therapies any more effective than platform therapies in boosting cognition? Share on Facebook ...